Abstract
Keywords
Get full access to this article
View all access options for this article.
References
1.
Fowler
J
Jarratt
M
Moore
A
et al
. Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment for . Br J Dermatol . 2012 ;166 633 -641 .
2.
Moore
A
Kempers
S
Murakawa
G
et al
. Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% . J Drugs Dermatol . 2014 ;13 :56 -61 .
3.
Manni
G
Centofanti
M
Sacchetti
M
et al
. Demographic and clinical factors associated with development of brimonidine . J Glaucoma . 2004 ;13 :163 -167 .
4.
Cookson
H
McFadden
J
White
J
White
IR.
Allergic contact dermatitis caused by Mirvaso(R), brimonidine tartrate gel 0.33% . Contact Dermatitis . 2015 ;73 :366 -367 .
5.
Rajagopalan
A
Rajagopalan
B.
Allergic contact dermatitis to topical brimonidine . Australas J Dermatol . 2015 ;56 :235 .